chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Again sick with COVID-19 like symptoms; Again sick with COVID-19 like symptoms; Again sick with COVID-19 like symptoms; weight loss; This is a spontaneous report from a non-contactable consumer via a Pfizer sales representative. A male patient of an unspecified age received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included COVID-19 from Nov2020 to an unknown date (for 13 days and experienced weight loss), weight decreased from 2020 to an unknown date. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) for COVID-19 immunisation and experienced sick with COVID-19 like symptoms. Concomitant medications were not reported. The patient experienced again sick with COVID-19 like symptoms (medically significant) in Apr2021 with outcome of recovered in 2021 and weight loss in Apr2021 with outcome of unknown. The reporter stated that his friend received 1st and 2nd dose in Apr2021. In Nov2020 he was sick with a confirmed COVID-19 infection for 13 days and experienced weight loss. Following the first dose of vaccine in Apr2021 he was sick with COVID-19 like symptoms for approximatively 2-3 days. The symptoms were similar to when he had COVID-19 infection in Nov2020. Following the second dose he was again sick with COVID-19 like symptoms for approximatively 10 days and experienced weight loss.  The lot number for bnt162b2 was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101138866 Same patient/drug, different dose/events
Dizzy- continued for over 3 weeks; Headache - off and on for weeks; Fatigue- over 3 weeks; Sore arm for few days; Diarrhea- day 3; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. On 10Aug2021, the patient was dizzy which continued for over 3 weeks. The patient also experienced headache which was off and on for weeks and had fatigue for over 3 weeks. The patient had sore arm for few days and experienced diarrhea-day 3. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy, headache, fatigue, sore arm and diarrhea were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe lasting pain in upper arm muscle, drastically reduced range of motion, inability to sleep due to pain.
Left deltoid, warm to touch, discoloration and swelling began yesterday 4/23/13. Advised ice and BENADRYL.
Patient immediately had soreness and pain in the R shoulder joint which is constant and only minimally responds to ibuprofen. Has had the pain for a month at this point. Pain started immediately. Suspicion for SIRVA because vaccine was administered high in the arm.
pt recv vax; on 25th july pt stopped breathing & started shaking;at mid noc amb called;to er;adm to hosp for monitoring;pt still being tested & has been placed on sz meds;cause of sz not yet been determined;mom will call for more info;
Initial unsolicited report received from consumer via social media on 09 Jul 2016. This case is linked to 2016SA128403, 2016SA131479, 2016SA131491 (same vaccine, same reporter). This case involves a patient (age and gender: not reported) who was vaccinated with dose of MENINGOCOCCAL VACCINE (batch number, expiry date, route, dose and site of administration: not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, two weeks after getting the vaccination the patient died. It was unknown whether autopsy was performed. Documents held by sender: none.; Sender's Comments: This case corresponds to a poorly documented and non-medically confirmed social media report. Patient presumably received meningococcal vaccine for which the manufacturer was unknown. Clinical details- such as patient's age, medical history, vaccination details, the name of the specific vaccine administered, clinical details surrounding the event, diagnostic work-up, cause of death and autopsy reports- are lacking to allow adequate medical assessment. Reported Cause(s) of Death: death.
Seasonal influenza vaccine. Patient reported the day after vaccination to have 8/10 pain in the left lateral and posterior shoulder with difficulty abducting the left arm without assistance. Pain has been progressive.
Information has been received from a physician and assistant concerning a 4 year old male patient with no pertinent medical history and no allergies who on 25-AUG-2010 was vaccinated with the second dose of MMR II (lot# 667006/0256Z). There was no concomitant medication. On 25-AUG-2010, within 4 hours of vaccination with his 2nd dose of MMR II, the patient developed a fever of 104F. Unspecified medical attention was sought via phone call. The patient's fever persisted. Follow up information has been received from the physician concerning the 4 year old male patient who on 25-AUG-2010 was vaccinated with the second dose of MMR II (lot# 667006/0256Z) into his arm. There was no illness at time of vaccination. On 25-AUG-2010, in the afternoon, approximately 2 to 4 hours after injection with his 2nd dose of MMR II, the patient developed a fever of 104F. At the time of this report, the patient had recovered. The physician advised that the patient in this case had a cousin who lived upstairs from him. The cousin had coxsackie. The cousin did not receive MMR II. The physician mentioned it because the patient had been playing with the cousin, but nothing developed from his exposure to his cousin. The patient was fine. Additional information is not expected.
Pain, a little redness, itching at injection site; Pain, a little redness, itching at injection site; Pain, a little redness, itching at injection site; Fatigue; Slight, intermittent headache; Mild chills; feeling cold from the inside; Moderate flu-like muscle pains in the back muscles; Mild nausea; loss of appetite; Bed rest with elevated head; This is a spontaneous report from a contactable consumer (patient). A 63-year-old non-pregnant female patient received third (booster) dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0196), via an unspecified route of administration, administered in right arm on 14Oct2021 10:30 (at the age of 63-years) as dose 3 (booster), single for COVID-19 immunization. Patient relevant medical history includes mild hypertension, and allergy to cats, some dogs, dust, some pollen, and allergy to ibuprofen, allergy to sumatriptan, allergy to bactrim DS, allergy to pamabrom, allergy to meloxicam. The patient concomitant medication includes losartan 50mg, hydrochlorothiazide 12.5mg, tylen, and flu vaccine VII (INFLUENZA VACCINE), administered in right arm on 04Oct2021 for Immunization. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, batch number: EL3247), administered in left arm on 02Mar2021 (at the age of 63-years), as a single dose, and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, batch number: EL3247), administered in left arm on 25Mar2021 (at the age of 63-years), as a single dose for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 15Oct2021, the patient experienced Pain, a little redness, itching at injection site; Fatigue; Slight, intermittent headache; Mild chills; feeling cold from the inside out; Moderate flu-like muscle pains in the back muscles; Mild nausea; loss of appetite; and Bed rest with elevated head. The patient received tylenol 650mg 4x over 48 hrs as a treatment for the adverse events. The outcome of events was recovering, and event fatigue was recovered on 17Oct2021.  Follow-Up (20Oct2021): Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 01-NOV-2015 14:17, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 5.7 and 2.5 respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Overnight, approximately 12 hours after the vaccine, I had extreme chills (while sleeping, approximately 3:30 am) and within two hours we recorded a fever of 102.3. I also experienced extreme fatigue, overall body pain, extreme pain & swelling  at the injection site,  nerve pain and numbness from the injection site (upper left arm) down through and including left hand and fingers. I also had continuous headache, and nausea. I was also dizzy and unable to stand up easily for several hours. I also had diarrhea.  I took Tylenol for the fever, but it only came down to 101. It spiked again to 102, and I took Tylenol again, In the evening, the fever broke, and I immediately started feeling better. Today (48 hours after injection) I am still weak and dizzy, and my arm is still in a lot of pain. i also still have numbness in the same arm.  One more thing, when I was driving home from the vaccine appointment, I felt tingling in my throat. That stopped after about an hour.
This spontaneous report was received from a Licensed Practical Nurse and refers to a 74-year-old patient. No information regarding the patient's medical history and concurrent conditions was provided. On an unknown date, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (dose and route of administration were not reported) lot # N024384 with expiration date on 18-MAY-2019. The vaccine underwent a temperature excursion of 0.1 degrees Celsius for 6 hours. Digital data logger was involved in the recording of the excursion. Unspecified previous excursions were reported. No adverse events were reported. This is one of several reports received from the same source.; Sender's Comments: US-009507513-1712USA001322: US-009507513-1712USA001321: US-009507513-1712USA009066:
I gave the patient pentacel, but only the diluent was given. Instead of the complete pentacel portion.
Cellulitis, abscess formation at site of varicella injection on left thigh; patient admitted 12 days after receiving vaccinations for PENTACEL, PREVNAR, MMR, Varicella on b/l thighs.
Upper L arm pain-does have spasms no injury, had Td on 9/16/02. Very tender L upper arm no swelling or redness. Good range of motion except straight raising up is with pain. No other findings noted. Advil 200mg x 1-2d.
After 1st, shot, within days I developed painful sinus pressure in cheek above left jaw that persisted for a week, followed by constant pressure and mucus drainage; coughing; wheezing; sneezing. After 2nd shot, same as above has persisted. HOWEVER, I have not menstruated ! I had typical period pains, felt like I was going to start on schedule, but I have not to date. All typical menstral pains are now gone.  Date of last cycle began normal on 6/5/21, lasted 4 days.
8 pm on evening of vaccination unable to use L arm + dull pain to L side and into breast area.  Woke up next day at 6 am with a rash from sternum to groin area.  Rash resolved in 24 hours.  Pain to L arm resolved in 1 week.  Contacted physician who advised not to complete preexposure.
Information has been received from a registered nurse and a family nurse practitioner, for GARDASIL, a Pregnancy Registry product, concerning a 24 year old female case worker with (GERD) Gastrooesophageal reflux disease who on 23-JUN-2011, 26-JUL-2011 and 20-DEC-2011 was vaccinated with her first, second and third dose of GARDASIL (lot number: first dose 668229/1569Z, second dose 668229/1569Z and third dose 671006/1291AA) respectively. On 06-OCT-2011 the patient had a spontaneous abortion 11 weeks from LMP (last menstrual period approximately on 20-JUL-2011). It was unspecified if the patient sought medical attention. At the time of the report, outcome of the event was unknown. Upon internal review, the patient's spontaneous abortion was determined to be an other important medical event. The patient subsequently became pregnant again (LMP reported as 26-OCT-2011) while on therapy with GARDASIL (WAES # 1112USA02770). Additional information has been requested.
soreness; lump in his injected arm; I touch it and I feel it kind of a little bit sore/dull ache; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), second dose via an unspecified route of administration on 17May2021 as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date was not reported), first dose via an unspecified route of administration on unspecified date as single for covid-19 immunisation. On an unspecified date of 2021 the patient reports that since then, he had been feeling soreness and a lump in his injected arm. Patient stated, "I feel like they got me on the nerve" and also, "I touch it and I feel it kind of a little bit sore, no redness. Just a dull ache every once in a while". Patient had been monitoring his blood pressure and heart rate and reports that "everything is good". The outcome of the events was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Immediate swelling at injection site that was approximately 2 inches wide with a hard lump in the middle.  The swelling began to go down after approximately five minutes, but remained elevated.  There was no itching, redness, warmth, or bruising at the site.  The patient was observed for approximately 20 minutes.  She was questioned if she was experiencing any SOB, wheezing, dizziness. The patient was ready to leave and did not want to wait any longer.  She was called later and attested that the swelling had gone down and there was only a hard knot.  The patient came into the pharmacy on 10/28/11 to be observed.  The swelling was gone, but a small knot could be palpated but not visible.  The patient reported some injection site pain that was not out of the ordinary after an intramuscular injection.  She endorses that it is controlled with Tylenol.
Pt calls in to nurse triage at 12:06 pm on 4/8/22 with concerns of Tdap immunization reaction. She got an intramuscular injection in the left deltoid. Pt states she feels like she has a painless bump around the site and some localized hives on that arm. Pt was advised of pt home care advice at this time. She was negative for all emergent protocol symptoms at this time.   HOME CARE: You should be able to treat this at home.  TD OR TDAP VACCINATION LUMP:  * A painless lump (or nodule) sometimes develops at the Td or Tdap injection site 1 or 2 weeks later. * It is harmless and usually will disappear in about 2 months.  CALL BACK IF: * Fever lasts more than 3 days * Pain lasts more than 3 days * Injection site starts to look infected * You become worse  TETANUS-DIPHTHERIA-PERTUSSIS (TDAP) VACCINE: * Pain and tenderness at the injection site (in 66%).  * Mild redness and mild swelling at the injection site (in 20%).  * Fever over 100.4 F (38.0 C) (in 1 %) and fever over 102 F (38.9 C) (in 0.4%). * Malaise, nausea, headache, body aches.  TETANUS-DIPHTHERIA-PERTUSSIS (TDAP) VACCINE: * Anaphylactic reaction (acute severe allergic reaction with wheezing, shock) Original Version: TETANUS-DIPHTHERIA-PERTUSSIS (TDAP) VACCINE:          * Anaphylactic reaction (acute severe allergic reaction with wheezing, urticaria, shock)  TETANUS-DIPHTHERIA (TD) VACCINE: * Anaphylactic reaction (acute severe allergic reaction with wheezing, shock)  * Brachial plexus neuropathy (deep ongoing upper arm pain with muscle atrophy and weakness) * Guillain Barre Syndrome * Sterile abscess  Pt was advised to take benedryl at this time. She was advised if she were to have any swelling in her face and lips, developed difficulty breathing, signs of infection as detailed with patient she was to seek emergency department or call EMS. Pt verbally agrees to understanding. Writer contacted patient again at 12:22 to check on her status and she had not yet taken any medication as advised but reported her status as being the same as time of call.
Patient administered 1st dose Pfizer Vaccine 03.mL IM Left deltoid by RN on 7/20/21 at 11:00. Patient stayed for observation. Reported "red rash on both hands" 7/20/21 at 11:18. EMT and NP notified at this time. Patient assessed by NP and cared for by EMT and NP. Onset 18 minutes post vaccination. Location bilateral palmar surface of hands. Character was slightly erythematous. Possible association with vaccine administration 18 minutes prior. Patient well developed in non-acute distress.  Responsive to NP.  Answers questions. Alert and oriented x4. Denied any other symptoms to include shortness of breath, chest pain, trouble breathing. Lungs clear to auscultation throughout, heart regular rate and rhythm. VS- BP-138/86, HR-96, RR-20. Mild erythematous rash bilaterally palmar surface of hands. Relieving factors Benadryl 25mg/0.5mL administered by NP IM Right deltoid 7/20/21 at 11:20 with verbal orders with collaborative physician Dr.. Dr. came to patient to assess. Continued patient monitoring for 30 minutes. Rash completely resolved by 7/20/21 at 11:35. Patient reassessed. Stable. Patient denied any other symptoms. Recommended Benadryl 25-50mg by mouth as needed every 4-6 hours for the next 12 hours. Instructed to wait at least 6 hours from IM injection at clinic. Patient educated about s/s of allergic and anaphylactic reactions. Monitor for chest pain, shortness of breath, trouble breathing, fever. For these emergent symptoms call 911 immediately and go directly to Emergency Department. Patient has scheduled appointment with primary care provider 8/13/2021. For further questions refer to PCP.  Emergencies refer to ED.
A report has been received from a Health Professional concerning a, male patient, who had been receiving FLUMIST. FLUMIST started on an unknown date. The patient was administered a partial dose of FLUMIST by a Pharmacist on December 12, 2015. The pharmacist successfully administered the first half of the dose, but the child moved away during administration of the second half of the dose. The outcome of the event of partial dose administered was unknown. The report was considered to be non-serious.
Information has been received from a health professional concerning a female who was vaccinated with varicella virus vaccine live. At the time of vaccination, lab evaluation had revealed a negative pregnancy test. Approx. 2 weeks, post vax, the pt told the physician she was pregnant. Approx. 4-6 weeks later, the pt had a miscarriage. Medical attention was sought. No further information is available.
At the time of the vaccination, while administering the vaccine I bled profusely. I am not anemic and was not on any blood thinners. 10 days later it appears I had a TIA. I have not had COVID, I have no history of Afib, BP is good and normal, heart rate is healthy, cholesterol is normal to low. I am not overweight, have never smoked, and exercise daily for over an hour. 10 days after the vaccines, I was at my desk in the office, and felt fine except I was unable to write. I could hold the pen but I could not form letters properly as hard as I tried. I took low dose-aspirin and went to the Emergency Room. Heart echo and CT/MRI were all normal. I was kept overnight ofr observation and the symptons never returned. My ability to write returned after about 30 minutes.
Member complained of lightheadedness.  Monitored from 12:48 to 1:00pm.  Vital signs taken - within normal range. SpO2 at 99%.  Afterwards stated he felt dizzy as well, placed on gurney and encouraged to take deep breaths.  A few minutes later, stated he felt better and went home.
Patient received her first dose of shingrix on 04/28/19. She called the pharmacy on 04/30/19 complaining of rash on torso and under breast and that it had gotten worse overnight. She had called the cdc and fda prior to calling the pharmacy and they told her its an allergic reaction and to go to her doctor. I also told the patient to go to the doctor and monitor for signs of anaphylaxis and worsening reaction. Patient reported to her doctor who told her it was an allergic reaction and to take allegra every day and for 5 days after symptoms resolve.